Literature DB >> 20035822

Cysticercosis and neurocysticercosis as pathogens affecting the nervous system.

Siddhartha Mahanty1, Hector H Garcia.   

Abstract

Taenia solium cysticercosis is still a major cause of seizures around the world. Despite an extensive body of published literature on this topic, knowledge of the biology, immunology, pathophysiology, and treatment of this parasite remains largely incomplete. This review summarizes recent information on the biology, clinical manifestations, immunopathology treatment and control of this important and neglected zoonotic disease, with emphasis on areas where recent developments have changed traditional and established views. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20035822     DOI: 10.1016/j.pneurobio.2009.12.008

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  32 in total

1.  Neurocysticercosis.

Authors:  Oscar H Del Brutto
Journal:  Neurohospitalist       Date:  2014-10

Review 2.  Microbes' roadmap to neurons.

Authors:  Krister Kristensson
Journal:  Nat Rev Neurosci       Date:  2011-05-18       Impact factor: 34.870

3.  [Pain in the ankle and forefoot : Not always a traumatic cause].

Authors:  T M Schneider; T Pausch; F Andre; M-A Weber; S D Sprengel
Journal:  Radiologe       Date:  2017-09       Impact factor: 0.635

4.  Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis.

Authors:  Uma Mahesh Gundra; Bibhuti B Mishra; Kondi Wong; Judy M Teale
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

5.  Galectin-3 in M2 Macrophages Plays a Protective Role in Resolution of Neuropathology in Brain Parasitic Infection by Regulating Neutrophil Turnover.

Authors:  Fredice O Quenum Zangbede; Arun Chauhan; Jyotika Sharma; Bibhuti B Mishra
Journal:  J Neurosci       Date:  2018-06-26       Impact factor: 6.167

6.  Cysticercosis, a Potential Public Health Concern in Kuwait: A New Diagnostic Method to Screen Taenia solium Taeniasis Carriers in the Expatriate Population.

Authors:  Mohammad Al-Awadhi; Jamshaid Iqbal; Suhail Ahmad
Journal:  Med Princ Pract       Date:  2019-11-08       Impact factor: 1.927

7.  Neurocysticercosis: an update.

Authors:  Christina M Coyle
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

8.  Immune-inflammatory markers in massively disseminated cysticercosis.

Authors:  Akhila Kumar Panda; Binod Kumar Pati
Journal:  BMJ Case Rep       Date:  2014-04-09

Review 9.  Corticosteroid use in neurocysticercosis.

Authors:  Theodore E Nash; Siddhartha Mahanty; Hector H Garcia
Journal:  Expert Rev Neurother       Date:  2011-08       Impact factor: 4.618

10.  Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.

Authors:  Hector H Garcia; Isidro Gonzales; Andres G Lescano; Javier A Bustos; Mirko Zimic; Diego Escalante; Herbert Saavedra; Martin Gavidia; Lourdes Rodriguez; Enrique Najar; Hugo Umeres; E Javier Pretell
Journal:  Lancet Infect Dis       Date:  2014-07-03       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.